SARS-CoV-2 vaccines for cancer patients: a call to action - European Journal of Cancer
Immunization Action Coalition (IAC): Vaccine Information for Health Care Professionals
Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities: Molecular Therapy
Frontiers | Advances in mRNA Vaccines for Infectious Diseases | Immunology
Improving vaccination coverage in India: lessons from Intensified Mission Indradhanush, a cross-sectoral systems strengthening strategy | The BMJ
A brief review on Group A Streptococcus pathogenesis and vaccine development | Royal Society Open Science
SARS-CoV-2 Vaccine Development: Current Status - Mayo Clinic Proceedings
Vaccination and multiple sclerosis in the era of the COVID-19 pandemic | Journal of Neurology, Neurosurgery & Psychiatry
Conjugate Vaccine Immunotherapy for Substance Use Disorder | Pharmacological Reviews
Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development - eBioMedicine
Immunoregulatory functions of immune complexes in vaccine and therapy | EMBO Molecular Medicine
About Sputnik V | Official website vaccine against COVID-19 Sputnik V.
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates - The Lancet
SARS-CoV-2 Vaccine Development: An Overview and Perspectives | ACS Pharmacology & Translational Science
Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities: Molecular Therapy
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates - The Lancet
Nanoparticle-based delivery platforms for mRNA vaccine development
A prospective observational safety study on ChAdOx1 nCoV-19 corona virus vaccine (recombinant) use in healthcare workers- first results from India - eClinicalMedicine
Live attenuated vaccines, a favorable strategy to provide long-term immunity against protozoan diseases: Trends in Parasitology
Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19: JACC State-of-the-Art Review | Journal of the American College of Cardiology
Vaccines
RNA to the rescue: RNA is one of the most promising targets for drug development given its wide variety of uses: EMBO reports: Vol 21, No 7
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement - The Lancet Gastroenterology & Hepatology
